# Early Initiated Ambulance-delivered Levetiracetam and Headposition in Hyper-acute Stroke Trial

> **NCT06773364** · PHASE3 · RECRUITING · sponsor: **Shanghai East Hospital** · enrollment: 2423 (estimated)

## Conditions studied

- Suspected Stroke

## Interventions

- **DRUG:** Levetiracetam
- **OTHER:** Guide-recommended management
- **OTHER:** The lying flat (0°) head position
- **OTHER:** The sitting-up (≥30°) head position

## Key facts

- **NCT ID:** NCT06773364
- **Lead sponsor:** Shanghai East Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-30
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 2423 (ESTIMATED)
- **Last updated:** 2025-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06773364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06773364, "Early Initiated Ambulance-delivered Levetiracetam and Headposition in Hyper-acute Stroke Trial". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06773364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
